as 03-11-2025 4:00pm EST
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | BANNOCKBURN |
Market Cap: | 5.3B | IPO Year: | N/A |
Target Price: | $33.00 | AVG Volume (30 days): | 1.7M |
Analyst Decision: | Buy | Number of Analysts: | 7 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.23 | EPS Growth: | -16.89 |
52 Week Low/High: | $21.39 - $34.85 | Next Earning Date: | 04-22-2025 |
Revenue: | $4,998,202,000 | Revenue Growth: | 16.17% |
Revenue Growth (this year): | 10.06% | Revenue Growth (next year): | 8.56% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Bavaro Michael | OPCH | Chief Human Resources Officer | Feb 28 '25 | Sell | $33.26 | 30,996 | $1,030,843.27 | 44,974 |
OPCH Breaking Stock News: Dive into OPCH Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Zacks
5 days ago
StockStory
6 days ago
Zacks
6 days ago
StockStory
7 days ago
Investor's Business Daily
7 days ago
Argus Research
7 days ago
Zacks
7 days ago
The information presented on this page, "OPCH Option Care Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.